| Why sleep matters—the economic costs of insufficient sleep: a cross-country comparative analysis M Hafner, M Stepanek, J Taylor, WM Troxel, C Van Stolk Rand health quarterly 6 (4), 2017 | 756 | 2017 |
| Future of fentanyl B Pardo, J Taylor, JP Caulkins, B Kilmer, P Reuter, BD Stein | 135 | 2019 |
| Estimating the economic costs of antimicrobial resistance: model and results J Taylor, M Hafner, E Yerushalmi, R Smith, J Bellasio, R Vardavas, ... Santa Monica, CA: RAND Corporation, 2014 | 114 | 2014 |
| Estimating the economic costs of antimicrobial resistance J Taylor, M Hafner, E Yerushalmi, R Smith, J Bellasio, R Vardavas, ... Model and Results (RAND Corporation, Cambridge, UK), 2014 | 51 | 2014 |
| The dawn of a new synthetic opioid era: the need for innovative interventions B Pardo, J Taylor, J Caulkins, P Reuter, B Kilmer Addiction, 2020 | 40 | 2020 |
| Considering heroin-assisted treatment and supervised drug consumption sites in the United States B Kilmer, J Taylor, JP Caulkins, PA Mueller, AJ Ober, B Pardo, R Smart, ... RAND, 2018 | 36 | 2018 |
| The impact of the national minimum wage on employment M Hafner, J Taylor, P Pankowska, M Stepanek, S Nataraj, C van Stolk Cambridge, UK: Rand Europe, 2017 | 31 | 2017 |
| Are better health outcomes related to social expenditure J Rubin, J Taylor, J Krapels, A Sutherland, M Felician, J Liu, L Davis, ... A cross-national empirical analysis of social expenditure and population …, 2016 | 30 | 2016 |
| Imagining a fentanyl future: Some consequences of synthetic opioids replacing heroin P Reuter, B Pardo, J Taylor International Journal of Drug Policy, 103086, 2021 | 29 | 2021 |
| The Cost of Non-Europe in the Area of Organised Crime and Corruption: Annex II-Corruption M Hafner, J Taylor, E Disley, S Thebes, M Barberi, M Stepanek, M Levi RAND, 2016 | 24 | 2016 |
| Intermediate outcomes of arts projects: a rapid evidence assessment N Burrowes, E Disley, M Liddle, M Maguire, J Rubin, J Taylor, S Wright National Offender Management Services, 2013 | 24 | 2013 |
| Why sleep matters—the economic costs of insufficient sleep: a cross-country comparative analysis. Santa Monica, CA: RAND Corporation; 2016 M Hafner, M Stepanek, J Taylor, WM Troxel, C Van Stolk | 21 | 2016 |
| When Antibiotics Fail: The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada BB Finlay, J Conly, PC Coyte, JAR Dillon, G Douglas, E Goddard, L Greco, ... Council of Canadian Academies, 2019 | 20 | 2019 |
| Intermediate outcomes of mentoring interventions: a rapid evidence assessment J Taylor, N Burrowes, E Disley, M Liddle, M Maguire, J Rubin, S Wright London: National Offender Management Service, 2013 | 20 | 2013 |
| Illicit synthetic opioid consumption in Asia and the Pacific: Assessing the risks of a potential outbreak J Taylor, B Pardo, S Hulme, J Bouey, V Greenfield, S Zhang, B Kilmer Drug and Alcohol Dependence 220, 108500, 2021 | 19 | 2021 |
| Intolerance in Western Europe: Analysis of trends and associated factors J Rubin, J Taylor, A Pollitt, J Krapels, M Pardal RAND Corporation, 2014 | 19* | 2014 |
| Antimicrobial stewardship: The effectiveness of educational interventions to change risk-related behaviours in the general population: A systematic review S King, J Exley, J Taylor, K Kruithof, J Larkin, M Pardal Rand health quarterly 5 (3), 2016 | 17 | 2016 |
| 0803 WHY SLEEP MATTERS: THE MACROECONOMIC COSTS OF INSUFFICIENT SLEEP M Hafner, WM Troxel, M Stepanek, J Taylor, C Van Stolk Journal of Sleep and Sleep Disorders Research 40 (suppl_1), A297-A297, 2017 | 14 | 2017 |
| Mapping Diasporas in the European Union and the United States J Taylor, J Rubin, C Giulietti, C Giacomantonio, F Tsang, A Constant, ... IZA, 2014 | 13 | 2014 |
| Heroin-Assisted Treatment and Supervised Drug Consumption Sites: Experience from Four Countries L Strang, J Taylor RAND, 2018 | 12 | 2018 |
